Neuroendocrine differentiation in prostate cancer

被引：0
|
作者：
Jingwen WangYang Yao Department of OncologyShanghai Sixth Peoples HospitalJiaotong UniversityShanghai China [200233 ]
机构：
来源：
Chinese-German Journal of Clinical Oncology | 2008年 / 03期
关键词：
D O I：
暂无
中图分类号：
R737.25 [前列腺肿瘤];
学科分类号：
摘要：
Hormonal therapy is an important treatment for advanced/metastatic prostate cancer. But it can induce neuroen-docrine(NE) differentiation in prostate cancer cells. These NE cells will secrete manifold neural peptide or hormones which can lead to androgen-independent growth of non-NE tumor cells. When this happens,hormonal therapy becomes useless and indicates bad prognosis. In this paper,the mechanism of neuroendocrine differentiation and its relationship with andro-gen-independent were reviewed.
引用
收藏
页码：150 / 153
页数：4
相关论文
共 50 条
  • [21] Molecular aspects of prostate cancer with neuroendocrine differentiation
    Li, Qi
    Zhang, Connie S.
    Zhang, Yifen
    CHINESE JOURNAL OF CANCER RESEARCH, 2016, 28 (01) : 122 - 129
  • [22] Value of the detection of neuroendocrine differentiation in prostate cancer
    Kovylina, M. V.
    Prilepskaya, E. A.
    Sergeiko, I. P.
    Moiseenko, T. N.
    Kolantarev, K. B.
    Govorov, A. V.
    Pushkar, D. Yu.
    ONKOUROLOGIYA, 2013, 9 (04): : 43 - 46
  • [23] Immunohistochemical Analysis of Neuroendocrine Differentiation in Prostate Cancer
    Ishida, Eiwa
    Nakamura, Mitsutoshi
    Shimada, Keiji
    Tasaki, Masato
    Konishi, Noboru
    PATHOBIOLOGY, 2009, 76 (01) : 30 - 38
  • [24] Clinical implications of neuroendocrine differentiation in prostate cancer
    E C Nelson
    A J Cambio
    J C Yang
    J-H Ok
    P N Lara
    C P Evans
    Prostate Cancer and Prostatic Diseases, 2007, 10 : 6 - 14
  • [25] Clinical implications of neuroendocrine differentiation in prostate cancer
    Nelson, E. C.
    Cambio, A. J.
    Yang, J. C.
    Ok, J-H
    Lara, P. N., Jr.
    Evans, C. P.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2007, 10 (01) : 6 - 14
  • [26] Neuroendocrine differentiation in prostate cancer: Is it detectable and treatable?
    Birtle, AJ
    Freeman, A
    Payne, HA
    Masters, JRW
    Harland, SJ
    BJU INTERNATIONAL, 2003, 92 (04) : 490 - 490
  • [27] Proposed Morphologic Classification of Prostate Cancer With Neuroendocrine Differentiation
    Epstein, Jonathan I.
    Amin, Mahul B.
    Beltran, Himisha
    Lotan, Tamara L.
    Mosquera, Juan-Miguel
    Reuter, Victor E.
    Robinson, Brian D.
    Troncoso, Patricia
    Rubin, Mark A.
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2014, 38 (06) : 756 - 767
  • [28] Neuroendocrine differentiation of prostate cancer leads to PSMA suppression
    Bakht, Martin K.
    Derecichei, Iulian
    Li, Yinan
    Ferraiuolo, Rosa-Maria
    Dunning, Mark
    Oh, So Won
    Hussein, Abdulkadir
    Youn, Hyewon
    Stringer, Keith F.
    Jeong, Chang Wook
    Cheon, Gi Jeong
    Kwak, Cheol
    Kang, Keon Wook
    Lamb, Alastair D.
    Wang, Yuzhuo
    Dong, Xuesen
    Porter, Lisa A.
    ENDOCRINE-RELATED CANCER, 2019, 26 (02) : 131 - 146
  • [29] Current diagnostic procedure on neuroendocrine differentiation of prostate cancer
    Sciarra, Alessandro
    Innocenzi, Michele
    Ravaziol, Michele
    Minisola, Francesco
    Alfarone, Andrea
    Cattarino, Susanna
    Panebianco, Valeria
    Buonocore, Valeria
    Gentile, Vincenzo
    Di Silverio, Franco
    UROLOGIA JOURNAL, 2011, 78 (02) : 132 - 136
  • [30] The many faces of neuroendocrine differentiation in prostate cancer progression
    Terry, Stephane
    Beltran, Himisha
    FRONTIERS IN ONCOLOGY, 2014, 4
12345